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WS19.5 Health status in individuals with cystic ﬁbrosis over the period
of transition to adult services
A.H. Thorpe1, S.P. Conway1, T. Lee1, K. Brownlee1. 1Leeds Regional Paediatric
Cystic Fibrosis Centre, Leeds, United Kingdom
Objectives: There are few data examining what impact the potentially disruptive period
of transition to adult services has on the health of adolescents with CF. The aim was to
compare lung function, growth, co-morbidity and infection status pre and post transition
to assess any quantiﬁable change in clinical status.
51 consecutively transitioning adolescents (59% male, mean age 17.07 years) were
Identiﬁed. Markers of health were assessed in the 12 months before and after transition.
Methods: Z scores were calculated for height, weight and BMI. Lung function, positive
microbiology, courses of antibiotics, use of feeding supplements and presence of co-
morbidities in the 12 months pre and post transition were compared.
Results:
Growth
Variable Pre transition mean Post transition mean P value
Weight (kg) 58.21 58.94 0.16
Weight z score −0.50 −0.65 0.00089
Height (cm) 166.62 167.43 0.024
Height z score −0.57 −0.57 0.43
BMI (k/m2) 20.88 20.55 0.41
BMI z score −0.13 −0.30 0.004
There was no change in use of supplemental feeds. Nasogastric tubes were used in
more patients after transition.
Lung function
Mean change in
12 months before
transition
Mean change in
12 months after
transition
P value
% predicted FEV1 +1.11 −1 0.18
% predicted FVC +2 +0.6 0.92
There was no signiﬁcant change in P. aeruginosa infection status. Mean courses of
antibiotics did not differ in the 2 time periods.
Conclusion: The study population showed stable health status over the transition period.
This can be used as evidence to reassure individuals with CF, their families and care
providers.
WS19.6 The Frequent Flyer Programme: results of a 12-month quality
improvement initiative focused on intensive outpatient
physiotherapy and dietetic support
S.J. Ledger1, E. Owen1, A. Prasad1, J. Williams2, P. Aurora1. 1Great Ormond
Street Hospital for Children, Cystic Fibrosis Unit, London, United Kingdom;
2University College London, Institute of Child Health, London, United Kingdom
Introduction: Our current model of CF care is based on intensive inpatient in-
tervention. An alternative model providing comprehensive outpatient physiotherapy
and dietetic management to children with moderate-to-severe CF may be more
effective.
Objectives: To provide comprehensive outpatient physiotherapy, intensive exercise
and optimised nutritional support to reduce the number of hospital and home IV
days, and associated healthcare costs.
Methods: 16 children (12 female; 4 male; median age 11 (5−15) years) who
required >40 IV days in the previous 12-months were enrolled. Physiotherapy
included 1−2 weekly personal exercise training sessions; and airway clearance and
mucolytic inhalation techniques were reviewed monthly. Dietetic support included
nutritional education sessions and 1−2 monthly monitoring of growth, absorption,
appetite and intake.
Results: There was a 20% reduction (488 vs. 608 in previous year) in hospital IV
days and 40% reduction (203 vs. 339 in previous year) in home IV days during
the intervention year (p = 0.05). Cost analysis showed a saving of ±£102,000 to the
hospital. Training signiﬁcantly increased VO2peak by 4.8ml×kg×min−1 (p< 0.05),
10m-MSWT distance by 207m (p< 0.05) and level achieved by 2 (p< 0.05). No
signiﬁcant differences in lung function, weight, BMI and quality of life scores were
noted, although there was a trend towards improvement in outcomes compared to
the pre-intervention year.
Conclusion: This pilot programme demonstrated that an alternative outpatient
model can signiﬁcantly reduce IV days and cost of care, and improve exercise
capacity. A larger study is required to investigate impact on physiological and QoL
parameters.
